CPA
ASPN icon

Capital Performance Advisors’s Aspen Aerogels ASPN Stock Holding History

Capital Performance Advisors’s Portfolio ASPN Stock Details ASPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-15
Closed -$415 – 368
2024
Q3 		$415 Buy
+15
New +$375 ﹤0.01% 2330

Other funds holding ASPN

KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OCMI
Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return
GKFF
George Kaiser Family Foundation Tulsa, Oklahoma $883M AUM 21.04% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Performance Advisors's ASPN Position: Q4 2024 in Review

Capital Performance Advisors sold out of Aspen Aerogels (ASPN) in Q4 2024, closing a stake of 15 shares — an estimated $415 sold.

Capital Performance Advisors first reported a position in ASPN in Q3 2024 and held it in 1 quarter. The position peaked at $415 in Q3 2024. 231 funds tracked by Wall St. Rank hold ASPN as of Q4 2024.

  • Capital Performance Advisors reported no remaining Aspen Aerogels position as of Q4 2024 after selling out during the quarter.
  • Capital Performance Advisors sold 15 Aspen Aerogels shares in Q4 2024, an estimated $415.
  • Capital Performance Advisors first reported a position in Aspen Aerogels in Q3 2024 and held it in 1 quarter.
  • Capital Performance Advisors's Aspen Aerogels position peaked at $415 in Q3 2024.
  • 231 funds tracked by Wall St. Rank held Aspen Aerogels as of Q4 2024.

Based on Capital Performance Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.